Jeff Yass’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Other funds holding ACET
Jeff Yass's ACET Position: Q3 2026 in Review
Jeff Yass reduced its Adicet Bio (ACET) stake by 37% in Q3 2026, selling an estimated $67.2K and leaving 12,942 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12603.
Jeff Yass first reported a position in ACET in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.13M in Q1 2021. 54 funds tracked by Wall St. Rank hold ACET as of Q3 2026.
- Jeff Yass held 12,942 shares of Adicet Bio worth $92.4K as of Q3 2026.
- Jeff Yass sold 7,708 Adicet Bio shares in Q3 2026, an estimated $67.2K.
- Adicet Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12603 holding.
- Jeff Yass first reported a position in Adicet Bio in Q4 2019 and has held it in 22 quarters since.
- Jeff Yass's Adicet Bio position peaked at $1.13M in Q1 2021.
- 54 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.